Hungary embarks on approval process for Sinopharm COVID vaccine: foreign minister's spokesman
BUDAPEST (Reuters) - Hungary has embarked on the approval process for the Sinopharm coronavirus vaccine developed by the company's Beijing-based affiliate that got approved in China in December, the Hungarian foreign minister's spokesman said on Thursday.
"The approval process ... is under way ...under guidance of Hungarian experts," Tamas Menczer said in a reply to emailed questions from Reuters.
Hungary would be the first EU country to approve a Chinese vaccine.
(Reporting by Krisztina Than; editing by John Stonestreet)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.